Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Mama>99.0% (HPLC) API Falegaosi Mea Maualuluga
Tuuina atu le Sitagliptin Phosphate Monohydrate Fesoʻotaʻi Faʻatasi:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3
Igoa Vailaau | Sitagliptin Phosphate Monohydrate |
Synonyms | (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4- (2,4,5-trifluorophenyl)butan-1-tasi phosphate monohydrate |
Numera CAS | 654671-77-9 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C16H20F6N5O6P |
Molecular Weight | 523.3240802 |
Lisi Lisi | 202.0~204.0 ℃ |
Suavai Solubility | Solu i le Vai |
Ta'amilosaga Fa'apitoa | -18.0°~-23.0° (C=1, Vai) |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e i le Pa'u Pa'epa'e Pa'epa'e |
Faailoaina e le HPLC | Ole taimi ole fa'atumauina ole fa'ata'ita'iga e fetaui lelei ma tulaga fa'asino |
IR-Infrared Spectrum | Ole alaleo ole IR absorption ole fa'ata'ita'iga e tatau ona ogatasi ma alaleo masani |
Phosphate | E usitaia |
Mama / Suʻesuʻega Metotia | >99.0% (HPLC ile fa'amamago) |
Suavai (KF) | 3.3%~4.4% |
Toega i luga o le mumu | ≤0.20% |
Sulphate | ≤0.02% |
Klorida | ≤0.05% |
Chiral Le mama | <0.50% |
Mea Fa'atatau | |
Le mama nofofua | <0.50% |
Aofa'i Fa'aleaga | <1.0% |
Ethyl Acetate | <0.50% |
Metala mamafa | <20ppm |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | Vailaau Fa'atekonolosi |
afifi: Fagu, Ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau.
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu.
Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9), o se vailaʻau fou mo togafitiga o le maʻisuka ituaiga 2.I le masina o Aukuso 2009, na faʻamaonia ai le vailaʻau e le Iuni a Europa e avea o se vailaʻau muamua mo le togafitiga o le maʻisuka ituaiga 2.O le Sitagliptin Phosphate o le dipeptidyl peptidase-IV inhibitor muamua na faʻatagaina e le FDA e faʻaaogaina i togafitiga o le maʻisuka ituaiga 2 i le mamao, i lalo o le igoa fefaʻatauaʻiga Januvia.Dipeptidylpeptidase Ⅳ (DPP-Ⅳ) vave ma lelei faʻaleagaina le GLP-1, GLP-1, o le faʻamalosia sili ona aoga o le gaosiga o le inisalini ma le faʻalilolilo O le mea lea, o le taofiofia o le DPP-IV e mafai ona faʻaleleia ai le matafaioi a le GLP-1 endogenous, ma faʻateleina ai le toto. maualuga ole inisalini, e fa'aitiitia ai ma fa'atumauina le maualuga ole kulukose ile toto ile ma'i suka.I le taimi nei, ua faʻamaonia e vailaʻau o le DPP-IV inhibitor o se ituaiga fou o vailaʻau e puipuia ai le maʻisuka, ma o faʻaiʻuga a le falemaʻi e faʻaalia ai o vailaʻau e iai se aafiaga lelei o le hypoglycemic.Talu ai ona o le GLP-1 o loʻo faʻalagolago i le kulukose i le faʻalauiloaina o le gaosiga o le inisalini ma le faʻamalo, o aʻafiaga masani e pei o le hypoglycemia ma le paʻu mamafa e mafua mai i le faʻaaogaina o vailaʻau faʻamaʻi e le tupu.